Co-Diagnostics, a Salt Lake City company that was out of the gate early with a molecular COVID-19 test, announced this week that it has entered into an agreement with another Salt Lake City based company, Arches Research, a CLIA laboratory and subsidiary of PolarityTE to expand Arches’ COVID-19 testing services using Co-Diagnostics’ Logix Smart™ COVID-19 […]
Horizon Therapeutics has been named to PEOPLE’s 2020 “50 Companies That Care” list. Partnering with Great Place to Work, PEOPLE identified the top U.S. companies that went above and beyond in responding to the pandemic.The list, focused on employers with 1,000 or more employees, will be featured in the Sept. 14, 2020 print issue of […]
The CEOs of nine pharmaceutical manufacturers working on COVID-19 vaccines – AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer, and Sanofi – signed a pledge Tuesday to “uphold the integrity of the scientific process as they work towards potential global regulatory filings and approvals of the first COVID-19 vaccines.” In the pledge, the […]
Clene Nanomedicine, Inc., (“Clene”) a clinical-stage biopharmaceutical company and its Australian subsidiary, Clene Australia Pty Ltd., on Tuesday announced the completion of patient enrollment in its RESCUE-ALS Phase 2 study. The multi-center study is designed to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of CNM-Au8 in early symptomatic ALS patients. The objective of this study […]
Inherent Biosciences, a biotechnology company headquartered in Salt Lake City has announced a $255,959 award from the National Science Foundation (NSF) to study epigenetic biomarkers to predict patient response to COVID-19. The SBIR Phase I project aims to develop an onsite, clinical test to screen incoming patients potentially infected with COVID-19. The test would predict […]
This Utah Leads Together Accountability Framework presents Utah’s strategic, data-driven, and concentrated effort to protect the lives and livelihoods of all Utahns. The framework includes a clear mission, two major goals, six supporting objectives, and a variety of lead measures and strategies. A scorecard of measurable targets motivates progress. Together with a refined accountability structure, […]
By Chris Gibson, PhD via Recursion – Drug discovery partnership and equity investment led by Leaps by Bayer in Series D financing round – Digitally-powered drug discovery to address fibrotic diseases with previously undiscovered mechanisms and to deliver novel therapies to patients faster Berlin, Germany and Salt Lake City, USA, September 9, 2020 – Bayer and […]
By Adam Bonislawski for GenomeWeb NEW YORK – In a surprise move, the US Department of Health and Human Services said on Wednesday that it had determined the Food and Drug Administration would not require premarket review of laboratory-developed tests without notice-and-comment rulemaking. The announcement, which took many in the lab industry aback, appeared to […]
SALT LAKE CITY, August 26, 2020 – Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced that it has secured $42.5 million in a Series D financing. The round was led by SymBiosis II, LLC, a biotech-focused investment vehicle. Participants in the round included existing investors, as well as new institutional investors from South Korea […]
HHS said yesterday that it has determined that the FDA will not require premarket review of laboratory-developed tests (LDTs) without notice-and-comment rulemaking. This means that the FDA cannot expand its authority over LDTs through guidance and other informal issuances. As reported by Genome Web, it also means that laboratories will be able to “offer LDTs […]
BioUtah, along with 10 Utah biotech and biopharma companies, have sent letters to Utah’s U.S. Senators and Representatives urging opposition to the President’s directive to impose “most-favored nation” pricing on Medicare Part B drugs. The letter notes that if the executive order moves forward, investment dollars for Utah’s smaller drug discovery companies could dry up […]
On August 11, Altitude Lab, founded by BioUtah member Recursion and the University of Utah’s Center for Technology & Venture Commercialization (TVC), announced its first resident companies and opened applications for its unique collaborative facility and program. The incubator, a state-of-the-art 14,500 square foot lab facility, will offer resident companies workshops, mentoring, and non-dilutive funding […]